{
  "id": 4825448,
  "title": "Medizin: Novartis verkündet Studienerfolg von MS-Mittel",
  "url": "https://urgent.news/2026/09/01/medizin-novartis-verkundet-studienerfolg-von-ms-mittel",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-01T08:28:08.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/medizin-novartis-verkuendet-studienerfolg-von-ms-mittel/100251064.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "Medikamente gegen Multiple Sklerose brachten in der Vergangenheit oft starke Nebenwirkungen wie Leberschäden mit sich. Das neue Mittel von Novartis soll das ändern.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}